LLY - Lilly's donanemab effective for Alzheimer's disease FDA advisors say
2024-06-10 15:35:10 ET
More on Eli Lilly
- Lilly's donanemab, remternetug set to dominate Alzheimer's treatment by 2030
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- Eli Lilly's Growth And Challenges: A Cautious Buy
- Weight loss drugs other benefits could convince more men to use them - report
- Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript)